Used in research and development for Alzheimer’s disease diagnostics and therapeutics due to its specific binding to amyloid-beta peptides. It serves as a critical reference tool in immunoassays to detect and quantify amyloid-beta aggregates in biological samples. Commonly employed in ELISA, Western blotting, and immunohistochemistry to validate the presence of amyloid plaques, a hallmark of Alzheimer’s pathology. Also utilized in drug development to assess the efficacy of anti-amyloid compounds and in quality control of amyloid-targeting biologics. Its high specificity makes it ideal for standardizing assays across laboratories and clinical studies.